Nasdaq
$12.09▼ 0.04%vs prev close
🔒 Quotes & buy pressure are MAX onlySee plans
Market cap $3.02BShares out 2.500M sh
Chart
Filings & news by date
Hover (PC) or tap (mobile) a candle to see that day only
Filings
29- 6d agoPre-market26.10.19 19:564Ownership
Cellebrite DI Ltd.
David Barter, an officer of Cellebrite DI Ltd., has filed a Limited Power of Attorney to facilitate the reporting of insider transactions. This administrative filing authorizes designated company representatives to prepare and submit Forms 3, 4, 5, and 144 to the SEC on his behalf.…more
$12.09-0.04%vs prev closeDetected5m · 30m · 60m · Next dayPLUSView filingShare
- 10.9After-hours26.10.10 07:56SCHEDULE 13GOwnership
Cellebrite DI Ltd.
Pertento Partners LLP, Pertento Advisors LLC, and Eduardo Marques filed a Schedule 13G on October 9, 2026, regarding their ownership of Cellebrite DI Ltd. ordinary shares. This filing formalizes a joint filing agreement among the reporting persons concerning their stake in the company.…more
$12.09-0.04%vs prev closeView filingShare - 10.7Pre-market26.10.07 19:58144Ownership
Cellebrite DI Ltd.
David Barter, an insider at Cellebrite DI Ltd., has filed an SEC Form 144 to report a proposed sale of company securities. This filing serves as a standard notification of an insider's plan to dispose of their holdings.…more
$12.09-0.04%vs prev closeView filingShare
28 more filings
Sign up free to unlock the full feed and real-time filing & news alerts.
- ✓Free — no card required
- ✓Full real-time filing & news feed
- ✓Daily Today Report
News
GlobeNewswire- 9.14Pre-market26.09.14 21:05#●●●
Cellebrite Announces Corporate Reorganization to Redomicile in U.S.
Cellebrite has announced a corporate reorganization plan to redomicile to the U.S. by establishing a new American parent company. The transition is subject to shareholder and regulatory approvals and is expected to be completed by the first half of 2027.…more
$12.09-0.04%vs prev closeDetected5m · 30m · 60m · Next dayPLUSShareBenzinga